Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8232744 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
The maximum tolerated dose was determined to be 74 Gy/37 fractions (2.0 Gy per fraction) using three-dimensional conformal radiation therapy with concurrent paclitaxel and carboplatin therapy. This dose level in the Phase II portion has been well tolerated, with low rates of acute and late lung toxicities.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jeffrey D. M.D., Jennifer M.S., Mary V. M.D., Roger M.D., Ramaswamy M.D., Jack D.Sc., James A. Ph.D., Jeff M. M.D., Elizabeth M.D., Hak M.D.,